And last month we learned that Springsteen’s wife (and member of the E Street Band), Patti Scialfa ... Multiple myeloma is a relatively rare blood cancer that affects plasma cells, which ...

There are many preconceptions about cancer, even among patients with cancer. I have follicular lymphoma, a form of blood cancer that is considered highly treatable, but also chronic and incurable.

An indigenously developed gene therapy for specific blood cancers has shown a 73 per cent response rate among patients in India, according to results of clinical trials published in The Lancet ...

According to GLOBOCAN 2020 report, India witnesses approximately 13 lakh new cancer cases annually, and blood cancers have emerged as a significant health concern, particularly in urban centres ...

being a regular blood donor might also reduce your risk of developing certain blood cancers. The study compared the blood of 200 healthy male blood donors in their 60s. One group had donated blood ...

Researchers at the Francis Crick Institute have identified genetic changes in blood stem cells from frequent blood donors that support the production of new, non-cancerous cells. Understanding the ...

Japan's Ono Pharmaceutical is handing over $280 million upfront to acquire Ionis Pharmaceuticals’ phase 2-stage antisense oligonucleotide for a rare type of blood cancer. The RNA-targeted ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Dr. Raajit Rampal studies myelofibrosis in the lab and in the clinic. An international phase 3 clinical trial of a new drug combination for treating the blood cancer myelofibrosis found that adding a ...

People who give blood regularly are more likely to have genetic changes in their blood that could cut the risk of cancer developing, a study suggests. The researchers, from the Francis Crick ...

Get Instant Summarized Text (Gist) A rare side effect of CAR-T cell therapy for blood cancer, specifically T cell lymphoma, was identified in a 63-year-old patient. The tumor originated from ...